GOLDMAN SACHS GROUP INC - 30 Jun 2025 SCHEDULE 13G/A Report for SYNDAX PHARMACEUTICALS, INC. Common Stock (SNDX)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: SYNDAX PHARMACEUTICALS, INC. Common Stock
Symbol: SNDX
Shares outstanding: 85,874,278 shares
Disclosed Ownership: 5,581,828 shares
Ownership: 6.5%
Form type: SCHEDULE 13G/A
Filing time: 13 Aug 2025, 17:52:51 UTC
Date of event: 30 Jun 2025
Previous filing: 09 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	6.5%	5,581,828	0	5,581,718	Name:	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	6.5%	5,581,828	0	5,581,718	Name:	Attorney-in-fact